Physician

Amy Elizabeth Hogan-Moulton, MD

According to 2025 Medicare claims, Amy Hogan-Moulton, MD (NPI: 1730177825) practices nephrology in the Glens Falls, NY market, with the plurality of this provider's patient population coming from Warren, NY. This provider's primary affiliated billing organization is SARATOGA HOSPITAL (NPI: 1881924322; TIN: 141338547) and primary practice location at 12866-1003. Hogan-Moulton is affiliated with the Adirondacks ACO, LLC (ACO ID: A2193), participating under the MSSP model.

Hogan-Moulton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 627 traditional Medicare patients, billed 2,681 HCPCS/CPT codes, and received $245,964 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,135 prescription claims across 471 beneficiaries totaling $788,400 in drug costs, led by Jardiance (Empagliflozin). DME data shows 243 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $516,729 to $788,400. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $11,309 to $3,528.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	603	3,118	$286,760
2016	599	2,687	$285,967
2017	665	2,961	$314,815
2018	731	2,944	$310,916
2019	716	2,949	$344,176
2020	711	3,365	$317,651
2021	712	5,924	$374,230
2022	652	4,934	$320,693
2023	618	2,271	$293,105
2024	627	2,681	$245,964

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	361	3,612	$516,729
2016	392	4,137	$471,013
2017	359	3,335	$411,969
2018	362	2,805	$275,722
2019	376	2,278	$185,914
2020	397	1,701	$150,644
2021	376	1,720	$255,734
2022	421	1,818	$383,791
2023	459	1,898	$647,949
2024	471	2,135	$788,400

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	405	$123,950
2016	N/R	224	$60,208
2017	N/R	173	$37,803
2018	N/R	15	$324
2019	N/R	64	$16,022
2020	N/R	278	$55,002
2021	N/R	155	$14,529
2022	N/R	116	$2,392
2023	N/R	70	$2,373
2024	N/R	243	$3,842

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	93	107	$127
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	110	281	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	340	440	$80
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	91	227	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	113	122	$48

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	295	20,748	$398,716
Farxiga	Dapagliflozin Propanediol	106	8,478	$157,425
Veltassa	Patiromer Calcium Sorbitex	18	900	$29,161
Lokelma	Sodium Zirconium Cyclosilicate	25	1,125	$23,780
Cinacalcet Hcl	Cinacalcet Hcl	56	3,702	$17,066

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	64	$1,186
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	62	$853
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	15	$814
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	49	$541
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	53	$449

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Amy Elizabeth Hogan-Moulton, MD?

Tedicare shows public-source Medicare data for Amy Elizabeth Hogan-Moulton, MD (NPI 1730177825), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy Elizabeth Hogan-Moulton, MD have ACO affiliation data?

Amy Elizabeth Hogan-Moulton, MD is shown with ACO affiliation data for Adirondacks ACO, LLC (MSSP, ACO ID A2193).

What billing organization is linked to Amy Elizabeth Hogan-Moulton, MD?

Amy Elizabeth Hogan-Moulton, MD is linked to SARATOGA HOSPITAL (billing NPI 1881924322) in the available physician profile data.

Does Amy Elizabeth Hogan-Moulton, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.